CANDICE MYERS: Open Payments
NPI 1407234214 · YOUNGSVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 65 payments from 18 companies in 2025. Trend: 2023 $39 · 2024 $120 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $335 |
| Vanda Pharmaceuticals Inc. | 8 | $178 |
| Axsome Therapeutics, Inc. | 5 | $159 |
| Indivior Inc. | 9 | $138 |
| Braeburn Inc. | 8 | $135 |
| Corium, LLC | 6 | $74 |
| Alkermes, Inc. | 4 | $70 |
| Neurocrine BioSciences, Inc. | 2 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
Products named: SPRAVATO, FANAPT, Auvelity, SUBLOCADE, BRIXADI, Azstarys, INGREZZA, ARISTADA.
Industry payments across LA — which companies pay providers there.
